Related Experiment Video
Updated: Aug 21, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Left ventricular hypertrophy and its regression in essential arterial hypertension. A tissue Doppler imaging study
Vitantonio Di Bello1, Davide Giorgi, Roberto Pedrinelli
1Cardiac and Thoracic Department, University of Pisa, Pisa, Italy. vdibello@med.unipi.it
Insights
Pulsed-wave tissue Doppler imaging (TDI) effectively detects early left ventricular diastolic dysfunction in hypertensive patients. TDI parameters show improvement with antihypertensive treatment, aiding in assessing disease progression and treatment response.
Area of Science:
- Cardiology
- Medical Imaging
- Hypertension Research
Background:
- Essential hypertension is linked to left ventricular diastolic dysfunction.
- Assessing diastolic function in hypertensive patients is crucial for early intervention.
- Traditional methods may underestimate diastolic abnormalities in early stages.
Purpose of the Study:
- To evaluate the efficacy of pulsed-wave tissue Doppler imaging (TDI) in assessing left ventricular (LV) diastolic function in never-treated essential hypertensive patients.
- To compare TDI parameters with Doppler transmitral flow in discriminating diastolic dysfunction.
- To observe the impact of antihypertensive treatment on TDI parameters and LV hypertrophy (LVH).
Main Methods:
- Echocardiography was used to sample mitral annulus velocities via Doppler transmitral flow and pulsed-wave TDI.
- 118 never-treated essential hypertensive patients and 59 normotensive controls were studied.
- A subgroup of 26 hypertensive patients was followed for 1 year after antihypertensive treatment.
Main Results:
- TDI parameters (E(m), A(m), E(m)/A(m)) were significantly altered in hypertensive patients with LVH compared to controls.
- TDI E(m)/A(m) at the septal level discriminated normal from abnormal function in 91% of hypertensive patients, versus 25% for transmitral E/A ratio.
- Antihypertensive treatment led to LVH regression and a trend toward normalization of TDI parameters, particularly E(m)/A(m).
Conclusions:
- Pulsed-wave TDI is a sensitive tool for early detection of LV diastolic dysfunction in essential hypertension.
- TDI can identify patients in adaptive or compensatory phases before irreversible damage.
- TDI parameters show potential for monitoring treatment response and LVH regression.
Abstract:
The mitral annulus velocities of Doppler transmitral flow and pulsed-wave tissue Doppler imaging (TDI) were sampled by echocardiography for the assessment of left ventricular (LV) diastolic function in 118 never-treated essential hypertensive patients with normal systolic function and compared with those of 59 normotensive healthy subjects matched for age and sex. A selected group (n = 26) of the hypertensive study population was observed after 1 year of pharmacologic antihypertensive treatment to determine the behavior of TDI parameters in relation to eventual regression of LV hypertrophy (LVH). We found that the TDI early myocardial diastolic wave (E(m)) was significantly lower both in concentric and eccentric LVH. In addition, TDI late myocardial diastolic wave (A(m)) was significantly higher in concentric remodeling and concentric and eccentric hypertrophy. The TDI E(m)/A(m) ratio was significantly lower in all geometric remodeling subgroups. The E/A ratio Doppler transmitral flow velocity measured showed that of the 118 patients, only 32 (25%) could really be discriminated from normal, whereas individual analysis for TDI E(m)/A(m) at the mitral annulus septal level showed that of 118 patients 108 (91%) could be discriminated from normal P < .001). The LV mass was significantly less after 1 year of treatment (LVH regression), and TDI parameters showed a trend toward normalization, in particular of TDI E(m)/A(m) at the annular septal level. Pulsed-wave TDI analysis could enable not only the early assessment of whether a patient is still in an adaptive or compensatory phase before transition to irreversible damage (pathologic phase) but also the detection of precocious LV global diastolic dysfunction. With regard to this, more extensive randomized studies are needed to evaluate the effect of different pharmacologic treatments (calcium antagonists, beta-blockers, angiotensin I and II inhibitors) on TDI parameters.
Related Concept Videos
Heart Failure II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy

